GUARDIANTM SENSOR (3) CGM SYSTEM
Manage your glucose levels with a smarter continuous glucose monitoring (CGM) system, powered by Guardian™ Sensor (3).
SMART AND RELIABLE
A diagnostic chip automatically monitors sensor health every five minutes to improve sensor performance and reduce variability.
ACCURATE
Our most accurate sensor to date.§
CONVENIENT
Expect up to seven days of sensor life and a shorter start-up time.
The Guardian™ Sensor (3) is approved by Health Canada to be worn on either the abdomen, buttocks or on the back of the arm.†
SMARTGUARD™ TECHNOLOGY
Integrated with our latest advancement in insulin pump therapy, the Guardian Sensor (3) enables different levels of automation that fit your lifestyle.
- The MiniMed™ 670G system – Adaptive insulin delivery‡ and predictive low glucose suspend*
- Guardian™ Connect CGM System - predictive alerts up to 60 minutes in advance*
EXCLUSIVE CARELINK™ personal SOFTWARE
A web-based program that collects information directly from your Medtronic diabetes management system. It allows you to generate reports that can be used during your doctor’s visits and to monitor your own progress.
Frequently Asked Questions
How long can I wear the Guardian™ Sensor (3) before having to change it?
The intelligent diagnostics of the transmitter are continuously and proactively monitoring the health of the sensor. Guardian™ Sensor (3) can be worn for up to 7 days, however if your sensor is not performing well, you may receive a Change Sensor alert. Each monthly box of sensors includes 30 days of sensor wear to ensure you are only provided with safe, reliable and accurate sensor glucose values.
IMPORTANT SAFETY INFORMATION
GUARDIAN™ CONNECT CGM SYSTEM
- Do not use the Guardian Connect System for pediatric patients until you have thoroughly reviewed (with your Healthcare Professional), the system alert performance in the Guardian Connect Application User Guide and the sensor accuracy performance in the Guardian Sensor (3) Performance document. Discuss with your Healthcare Professional how to best set up your Guardian Connect System alerts to reduce the risk of missing low blood glucose or high blood glucose events.
- In the pediatric clinical study (3-18 years of age), larger differences were observed between the Guardian Connect System and actual blood glucose values compared to those differences observed in the adolescent/adult clinical study (14-75 years of age), particularly at low glucose levels.
- In the pediatric clinical study, a significant percentage of low glucose events were not detected by the Guardian Connect System. Do not rely solely on the Guardian Connect System alerts to detect low glucose.
- In the pediatric clinical study, the Guardian Connect System triggered a high percentage of false low glucose and false high glucose alerts. The Guardian Connect System is not intended to make therapy adjustments: always check your capillary blood glucose before making therapy adjustments.
- In the pediatric clinical study, enabling the ‘Alert Before Low’ and ‘Alert Before High’ predicted alerts significantly reduced the percentage of missed low blood glucose and missed high blood glucose events, but also significantly increased the percentage of false low glucose and false high glucose alerts. Do not ignore alerts from your Guardian Connect System. Always follow your treatment instructions from your Healthcare Professional when responding to an alert from your Guardian Connect System.
*
The Guardian Connect CGM System is intended for monitoring glucose levels in persons aged 3 years or older with diabetes mellitus. The MiniMed 670G system is intended for the management of Type 1 diabetes mellitus in persons age 7 and older requiring insulin.
†
In Canada, for persons 7-13 years of age, sensor placement and insertion has been studied in the belly (abdomen) and buttocks only and is not licensed for other sites.
For persons that are 14 years of age and older, sensor placement and insertion has been studied in the belly (abdomen) and back of upper arm only and is not licensed for other sites.
‡
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
§
Data on file. 2019
1
MiniMed™ 670G System SSED. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p160017. Accessed July 31, 2018. Arm insertion, 3-4 calibrations per day.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
